Acciones Gene Biotherapeutics, Inc. Other OTC
Acciones
CRXM
US8767671048
Biotecnología e investigación médica
Ventas 2019 | - | Ventas 2020 | - | Capitalización | 551 mil 515 mil |
---|---|---|---|---|---|
Resultado Neto 2019 | - 0 | Resultado Neto 2020 | - 0 | VE / Ventas 2019 | - |
Deuda neta 2019 | 1,12 M 1,05 M | Deuda neta 2020 | 874 mil 818 mil | VE / Ventas 2020 | - |
P/E ratio 2019 |
3,09
x | P/E ratio 2020 |
-1,77
x | Empleados | - |
Rendimiento 2019 * |
-
| Rendimiento 2020 |
-
| Flotante | 93,84 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 70 | 22/12/03 | |
James Grainer
CHM | Chairman | 69 | 22/05/20 |
Lois Chandler
COO | Chief Operating Officer | - | 01/07/10 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 70 | 22/12/03 | |
James Grainer
CHM | Chairman | 69 | 22/05/20 |
Ronald Shebuski
CTO | Chief Tech/Sci/R&D Officer | 71 | 22/05/20 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+1,51 % | 42,75 mil M | |
+49,22 % | 41,61 mil M | |
+8,57 % | 41,34 mil M | |
-12,36 % | 26,59 mil M | |
+8,92 % | 25,49 mil M | |
-25,13 % | 18,12 mil M | |
+29,17 % | 12,24 mil M | |
-3,12 % | 11,76 mil M | |
+6,35 % | 11 mil M |